| NCT ID | NCT04571086 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Essen |
| Condition | Malignant Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2020-04-30 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2020-04-30 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective observational trial investigating correlation with histopathology, positive predictive value, detection rate, reproducibility and impact on clinical management of 68-Ga-FAPI PET/CT or PET/MRI in patients receiving this imaging modality for tumor staging or restaging as part of clinical care.
Eligibility Criteria
Inclusion Criteria: 1. FAPI-PET scheduled for staging or restaging as part of clinical routine for proven or suspected malignancy 2. Age ≥ 18 years. Exclusion Criteria: 1. Patient cannot give consent for the study 2. Patient can not lie flat or tolerate FAPI PET imaging 3. Unwillingness or inability to comply with study and follow-up procedures 4. Condition of patient which is critical to participate in this study in the discretion of the investigators 5. Pregnant, lactating, or breast feeding women.
Contact & Investigator
Wolfgang Fendler, MD
PRINCIPAL INVESTIGATOR
University Hospital, Essen
Frequently Asked Questions
Who can join the NCT04571086 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Malignant Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04571086 currently recruiting?
Yes, NCT04571086 is actively recruiting participants. Contact the research team at wolfgang.fendler@uk-essen.de for enrollment information.
Where is the NCT04571086 trial being conducted?
This trial is being conducted at Essen, Germany.
Who is sponsoring the NCT04571086 clinical trial?
NCT04571086 is sponsored by University Hospital, Essen. The principal investigator is Wolfgang Fendler, MD at University Hospital, Essen. The trial plans to enroll 500 participants.